產品編號
1300235
CAS 號
20980-22-7
中文名稱
1-(2-嘧啶基)哌嗪(丁螺環酮雜質)
MDL 號
MFCD00040742
分子量
164.21
存儲條件
2-8°C, protect from light
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
31-35 °C
沸點
277 °C at 760 mmHg
閃點
旋光
描述
TPSA
41.05
LogP
-0.1138
H_Acceptors
4
H_Donors
1
Rotatable_Bonds
1
[1]. A H Vaidya, et al. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. Methods Find Exp Clin Pharmacol. 2005 May;27(4):245-55.
[2]. Donald M N Sikazwe, et al. Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups. Bioorg Med Chem. 2009 Feb 15;17(4):1716-23.
[3]. I Berlin, et al. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine. Br J Clin Pharmacol. 1995 Mar;39(3):243-9.
[4]. J Odontiadis, et al. Simultaneous quantitation of buspirone and its major metabolite 1-(2-pyrimidinyl)piperazine in human plasma by high-performance liquid chromatography with coulometric detection. J Pharm Biomed Anal. 1996 Jan;14(3):347-51.
[5]. Jinjun Wu, et al. The significant inhibition on CYP3A caused by radix Aconiti single herb is not observed in the Wutou decoction: The necessity of combination therapy of radix Aconiti. J Ethnopharmacol. 2015 Jul 21:170:251-4.
警示圖
警示詞
Warning
危險申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
GHS 編碼
GHS07
現貨供應
專業護航
售后無憂
品質保障
無需湊單